Smith Cynthia Insider Trades

Insider Trading History

Track insider trading activity for Smith Cynthia. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spero Therapeutics
Spero Therapeutics SPRO
Director
Holding Value $145k 85,000 shares
Last Trade
Jun 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64.5k 30,000 shares
$2.15
$1.70
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $608k 15,230 shares
Last Trade
Jun 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 2,816 shares
$34.16
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $597k 14,950 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$611k 17,877 shares
$34.16
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 2,816 shares
$34.16
$39.92
Akebia Therapeutics
Akebia Therapeutics AKBA
Director
Holding Value $275k 196,633 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.8k 89,300 shares
$0.94
$1.40
Protara Therapeutics
Protara Therapeutics TARA
Director
Holding Value $127k 31,000 shares
Last Trade
Jun 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$122k 31,000 shares
$3.94
$4.09
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.8k 2,302 shares
$35.08
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $496k 12,414 shares
Last Trade
Aug 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.8k 2,302 shares
$35.08
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $404k 10,112 shares
Last Trade
Jun 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $629k 15,768 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$560k 15,768 shares
$35.50
$39.92
Spero Therapeutics
Spero Therapeutics SPRO
Director
Holding Value $128k 75,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.8k 20,000 shares
$2.89
$1.70
Protara Therapeutics
Protara Therapeutics TARA
Director
Holding Value $98.2k 24,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.2k 24,000 shares
$3.26
$4.09
Akebia Therapeutics
Akebia Therapeutics AKBA
Director
Holding Value $225k 160,933 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 53,600 shares
$3.92
$1.40
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $319k 7,992 shares
Last Trade
Aug 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 2,302 shares
$43.70
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $91.9k 2,302 shares
Last Trade
Aug 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 2,302 shares
$43.70
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $470k 11,774 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 11,774 shares
$42.45
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$39.92
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $227k 5,690 shares
Last Trade
Jun 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$39.92
Protara Therapeutics
Protara Therapeutics TARA
Director
Holding Value $40.9k 10,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.7k 10,000 shares
$2.67
$4.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up